Cancer tracking co Navotek raises $4m
Dan Naveh's Agate fund invested in the firm, ahead of a larger round.
Navotek, which was founded in 2005, has developed a technology designed to deliver a greater level of accuracy in radiotherapy treatment of tumors. One of the main problems in treatment of this kind is that, in the attempt to remove growths, healthy tissue is invariably damaged in the process as well. The more focused the radiotherapy is on the growth itself, the greater the likelihood will be of avoiding damage to healthy tissue, and ensuring patients enjoy a reasonable quality of life after they recover.
Agate also recently invested $3 million in Tulip Medical Ltd., which is developing a intragastric implant for curbing appetite and treating obesity.
Published by Globes [online], Israel business news - www.globes-online.com - on September 15, 2008
© Copyright of Globes Publisher Itonut (1983) Ltd. 2008
- Tel Aviv market report
- Tel Aviv Stock Exchange
- Israeli stocks in NY
- Arbitrage gaps for dual-listed stocks
- Israeli stocks in Europe
- Israeli stocks on other markets
- Tel Aviv 25 options
- Mutual funds
- Current representative shekel rates
- Historical representative shekel rates
- Bank shekel rates
- Shekel/dollar options